Lithium Capsules and Loteprednol and Tobramycin
Determining the interaction of Lithium Capsules and Loteprednol and Tobramycin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Loteprednol and tobramycin (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Capsules-Loteprednol and tobramycin ophthalmic
- Lithium Capsules-Loteprednol Etabonate
- Lithium Capsules-Loteprednol Eye Drops
- Lithium Capsules-Loteprednol Eye Drops 0.2%
- Lithium Capsules-Loteprednol Eye Drops 0.5% and 1%
- Lithium Capsules-Loteprednol Eye Gel
- Loteprednol and Tobramycin-Lithium Capsules and Tablets
- Loteprednol and Tobramycin-Lithium Carbonate
- Loteprednol and Tobramycin-Lithium Carbonate ER Tablets
- Loteprednol and Tobramycin-Lithium Carbonate Tablets
- Loteprednol and Tobramycin-Lithium Citrate Syrup
- Loteprednol and Tobramycin-Lithium Controlled-Release and Extended-Release Tablets